Leap Therapeutics Ownership | Who Owns Leap Therapeutics?

Overview Forecast RevenueFinancials Chart

Leap Therapeutics Ownership Summary

Leap Therapeutics is owned by 26.63% institutional investors, 11.91% insiders, and 61.46% retail investors. Gilead sciences is the largest institutional shareholder, holding 12.83% of LPTX shares. Simplify Health Care ETF is the top mutual fund, with 2.02% of its assets in Leap Therapeutics shares.

LPTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Leap Therapeutics	26.63%	11.91%	61.46%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Gilead sciences	5.32M	12.83%	$2.41M
Acadian asset management	1.24M	2.98%	$560.00K
Vanguard group	1.16M	2.80%	$526.95K
Hightower advisors	1.10M	2.67%	$501.60K
Simplify asset management	975.61K	2.35%	$442.93K
Geode capital management	312.19K	0.75%	$141.82K
Jane street group	165.39K	0.40%	$75.09M
Key client fiduciary advisors	137.96K	0.33%	$62.63K
State street	125.61K	0.30%	$57.03K
Blackrock funding, inc. /de	125.23K	0.30%	$56.86K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Gilead sciences	5.32M	0.13%	$2.41M
Key client fiduciary advisors	137.96K	0.02%	$62.63K
Simplify asset management	975.61K	0.01%	$442.93K
Adar1 capital management	25.83K	0.00%	$11.73K
Acadian asset management	1.24M	0.00%	$560.00K
Cnb bank	5.00K	0.00%	$2.27K
Xtx topco	30.66K	0.00%	$13.92K
Hightower advisors	1.10M	0.00%	$501.60K
Hrt financial lp	118.63K	0.00%	$53.00K
Two sigma advisers, lp	99.68K	0.00%	$45.26K

Top Buyers

Holder	Shares	% Assets	Change
Jane street group	165.39K	-	165.39K
Hrt financial lp	118.63K	0.00%	118.63K
Simplify asset management	975.61K	0.01%	118.25K
Two sigma advisers, lp	99.68K	0.00%	58.40K
Two sigma investments, lp	70.85K	-	56.95K

Top Sellers

Holder	Shares	% Assets	Change
Samsara biocapital	-	-	-2.44M
683 capital management	-	-	-1.44M
Point72 asset management	-	-	-1.40M
Rock springs capital management lp	-	-	-1.27M
Monaco asset management sam	-	-	-1.05M

New Positions

Holder	Shares	% Assets	Change	Value
Hrt financial lp	118.63K	0.00%	118.63K	$53.00K

Sold Out

Holder	Change
Caldwell sutter capital	-4.00
Financial management professionals	-20.00
Newedge advisors	-82.00
Federation des caisses desjardins du quebec	-500.00
Us bancorp \de\	-610.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	24	-44.19%	11,035,559	-19.80%	26	2.40%	6	-62.50%	4	-60.00%
Jun 30, 2025	43	-8.51%	13,760,432	-17.57%	33	2.04%	16	-15.79%	10	-33.33%
Mar 31, 2025	47	-21.67%	16,693,179	-13.67%	40	1.53%	19	-44.12%	15	87.50%
Dec 31, 2024	60	25.00%	19,335,424	31.39%	51	4.04%	34	88.89%	8	-33.33%
Sep 30, 2024	48	-	14,716,283	-0.13%	35	2.52%	18	-30.77%	12	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Health Care ETF	837.65K	2.02%	-19.71K
Vanguard US Total Market Shares ETF	754.74K	1.83%	-
Vanguard Total Stock Mkt Idx Inv	738.59K	1.78%	-16.14K
Vanguard Institutional Extnd Mkt Idx Tr	270.89K	0.65%	-123.44K
BIT Biotech Opportunities S	192.30K	0.47%	-
Fidelity Extended Market Index	168.34K	0.41%	-1.19K
BlackRock Extended Equity Market K	82.86K	0.22%	-35.00
BIT Global Leaders I - I	81.00K	0.20%	-
Extended Equity Market Fund K	80.38K	0.19%	-1.60K
iShares Micro-Cap ETF	61.84K	0.15%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-

LPTX Ownership FAQ

Who Owns Leap Therapeutics?

Leap Therapeutics shareholders are primarily institutional investors at 26.63%, followed by 11.91% insiders and 61.46% retail investors. The average institutional ownership in Leap Therapeutics's industry, Biotech Stocks , is 45.24%, which Leap Therapeutics falls below.

Who owns the most shares of Leap Therapeutics?

Leap Therapeutics’s largest shareholders are Gilead sciences (5.32M shares, 12.83%), Acadian asset management (1.24M shares, 2.98%), and Vanguard group (1.16M shares, 2.80%). Together, they hold 18.62% of Leap Therapeutics’s total shares outstanding.

Does Blackrock own Leap Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Leap Therapeutics.

Who is Leap Therapeutics’s biggest shareholder by percentage of total assets invested?

Gilead sciences is Leap Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 5.32M Leap Therapeutics shares, valued at 2.41M$.

Who is the top mutual fund holder of Leap Therapeutics shares?

Simplify Health Care ETF is the top mutual fund holder of Leap Therapeutics shares, with 2.02% of its total shares outstanding invested in 837.65K Leap Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools